| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000267505.1 |
Afatinib |
Breast invasive carcinoma |
0.025614754 |
Resistant |
| ENSG00000267505.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.035962051 |
Resistant |
| ENSG00000267505.1 |
Afatinib |
Esophageal cancer |
0.036872768 |
Sensitive |
